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Role of simple and complex hybrid
revascularization procedures for symptomatic
lower extremity occlusive disease
Hasan H. Dosluoglu, MD,a,b Purandath Lall, MBBS,a,b Gregory S. Cherr, MD,b Linda M. Harris, MD,b
and Maciej L. Dryjski, MD,b Buffalo, NY
Objective: Hybrid reconstructions have been increasingly used for multilevel revascularization procedures as surgeons
have embraced endovascular interventions. The goal of this study is to define the role of simple and complex hybrid
techniques in patients who need multilevel revascularization.
Methods: All patients undergoing arterial revascularization (endovascular [EV], open, hybrid) between June 2001 and
May 2008 were included. Hybrid procedures were stratified as simple (sHYBRID group) when the endovascular-treated
segment was TransAtlantic Society Consensus II (TASC) A/B, and complex (cHYBRID group), when TASC C/D.
Results: Of the 654 patients, 770 limbs (67% critical limb ischemia), 226 (29%) had open, 436 (57%) had endovascular,
and 108 (14%) had hybrid procedures (56 sHYBRID, 52 cHYBRID). The HYBRID group was more likely to have
hypertension, chronic obstructive pulmonary disease, American Society of Anesthesia (ASA) 4, and aortoiliac reconstruc-
tions, with more ASA 4 in the cHYBRID than the sHYBRID group. Length of stay in the HYBRID group was
significantly longer than the EV group, but less than open-treated groups. Endovascular intervention was performed for
inflow in 85%, for runoff in 5%, and for both inflow and runoff in the remaining 10% of hybrid cases. Eleven (20%)
sHYBRID cases were staged, while all cHYBRID cases were performed simultaneously. Femoral endarterectomy was
more frequent in cHYBRID (75% vs 23% in sHYBRID), infrainguinal bypass (17% vs 55%) was more common in
sHYBRID, the remainder being femoro-femoral bypasses (8% vs 21%). Endovascular procedures were primarily iliac
interventions (91% in sHYBRID, 88% in cHYBRID). Thirty-day myocardial infarction/death rate was significantly
higher in the HYBRID than the EV group, with no difference within the HYBRID group. The patency rates were similar
in the sHYBRID and cHYBRID groups, and comparable to the endovascular and open treated patients with similar
disease complexity. Limb salvage in patients who presented with critical limb ischemia was better in the cHYBRID group
than other groups. Overall survival was similar in all groups.
Conclusions: Complex and simple hybrid procedures enable multilevel revascularizations in high-risk patients with
comparable patency and limb salvage. Femoral endarterectomy plays a central role, especially in complex hybrid repairs.
An increase in perioperative morbidity and mortality was observed in the hybrid group, likely due to attempting
revascularization in higher risk patients. ( J Vasc Surg 2010;51:1425-35.)The combination of endovascular procedures and open
bypass procedures has not only been increasingly used in
the last decade, but also has evolved in terms of complexity,
after the widespread adoption of these techniques by vas-
cular surgeons.1-5 The endovascular component of the
earlier reports on “combination” techniques mostly in-
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ses, and the open bypass was performed to treat the com-
plex anatomy of the multilevel reconstructions in high risk
patients, mostly presenting with critical limb ischemia.6-9 With
increased experience, the complexity of the endovascular-treated
segment increased,2,5,10 which paralleled the use of percu-
taneous revascularizations in patients who were previously
treated by combination methods.11-15
Although the term “hybrid” was not used in the earlier
reports, it has been increasingly used, especially when de-
scribing simultaneous multilevel reconstructions using both
endovascular and open revascularization techniques.1,5,16
Multilevel reconstructions using both techniques have
been performed both simultaneously, or in a staged fash-
ion. Reports of hybrid procedures usually include a variety
of clinical presentations, timing of endovascular and open
procedures, and technical aspects of the procedures, as well
as differing terminology, which makes it very hard for
making comparisons.2,5,17,18
We have been performing hybrid reconstructions since
2001 with increased complexity over time, and have noted
that the hybrid reconstructions consisted of a heteroge-
neous group, based on the timing (simultaneous vs staged),
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being simple and complex procedures. The goal of this
study is to define the role of simple and complex hybrid
techniques in patients who need multilevel revasculariza-
tion for their symptomatic peripheral arterial atheroscle-
rotic occlusive disease.
METHODS
Design and definitions. All consecutive patients who
presented to the Veterans’ Administration Western New
York Healthcare System between 6/1/2001 and 5/31/
2008 with symptomatic chronic limb ischemia (Rutherford
category 3-6)19 who underwent revascularization either by
endovascular (EV group), open bypass (OPEN group), or
combination of the two (HYBRID group) procedures were
identified, and retrospectively analyzed from our prospec-
tively maintained database. Patients in the HYBRID group
were further stratified based on the anatomic complexity of
the endovascular-treated segment. When the endovascular-
treated segment was classified as TransAtlantic Society
Consensus (TASC) II A or B,20 it was classified as a simple
hybrid (sHYBRID) procedure; when the endovascular-
treated segment was TASC II C or D, it was classified as a
complex hybrid procedure (cHYBRID). When the recon-
structions were performed in one setting, it was classified as
simultaneous; when it was performed in two, it was called a
staged hybrid procedure. The first cHYBRID reconstruc-
tion was performed on 9/26/2003, so we also reviewed
our experience before and after this period to see the
change of our practice and approach to lower extremity
revascularizations over time.
Methodology. The patients’ demographics, comor-
bidities, clinical presentation, non-invasive arterial studies,
other imaging studies, procedural details, the level(s) of
intervention (aortoiliac, inguinal [including the common
femoral and deep femoral], femoropopliteal or infrapopli-
teal), postoperative course, length of stay (LOS), follow-up
arterial studies, and condition on last follow up were re-
corded.
All procedures (endovascular, hybrid, open) were per-
formed by vascular surgeons in the operating room using
the OEC 9800 system (General Electric Medical Systems,
Salt Lake City, UT). The decision to proceed with endo-
vascular intervention, hybrid, or open bypass was made by
the vascular surgeon.
Techniques. In hybrid cases with iliac occlusions, we
attempted crossing the lesion in a retrograde fashion following
femoral artery exposure, employing the pre-arteriotomy
guidewire access (PAGA) technique, as was described previ-
ously.2,17 When a retrograde access failed, the iliac occlu-
sion was crossed in an antegrade fashion, and the guidewire
was retrieved during endarterectomy, as previously de-
scribed.21 Balloon expandable stents were preferentially
used in focal and calcified common iliac artery (CIA) le-
sions. Covered stents were used selectively.
In patients who needed a femoral endarterectomy and
superficial femoral artery (SFA) intervention, the SFA le-
sion was initially crossed, and arteriotomy then followed(PAGA). After the endarterectomy and suturing the patch, a
7F sheath was inserted between the untied sutures and was
cinched using rubber-shodded clamps, and the SFA interven-
tion was completed after the flow was re-established. The wire
and sheath were removed after completion angiogram.
When an inflow and an outflow procedure was planned,
the iliac and the SFA lesions were crossed using the stan-
dard techniques before arteriotomy was made (we call this
“double-PAGA”), and wires were left in the aorta and
popliteal artery during the endarterectomy and patch place-
ment (Fig 1). After sheaths were placed pointing in both
directions, flow was re-established. Iliac lesions were treated
first, followed by SFA intervention. Our technique for percu-
taneous interventions were previously described.22
Patients typically received 5000 to 6000 U of heparin
after a sheath was placed, which was not reversed at the end
of the procedure. All patients were kept on clopidogrel 75
mg and enteric coated acetyl salicylic acid (ECASA) 81 mg
for a minimum of 30 days, followed by lifelong ECASA.
Multilevel reconstruction was defined as those involv-
ing at least two levels (aortoiliac, inguinal, femoropopliteal,
or infrapopliteal). Technical success was defined as a patent
vessel with30% residual stenosis following postdilatation
with restoration of rapid antegrade perfusion. All patients
underwent surveillance by our vascular lab at 3 and 6
months and every 6 months thereafter, and by clinical
assessment (femoral and distal pulses), ankle-brachial index
(ABI) measurements, and angiography when clinically in-
dicated. Loss of patency was defined as a decrease in the
ABI of more than 0.15, unless the results of other exami-
nations demonstrated patency with significant stenosis. For
iliac lesions, patients with normal femoral pulse, without
symptoms and without decrease in ABI 0.15 were deter-
mined to have patent iliac segment. Patients with dimin-
ished femoral pulse, recurrent symptoms, and a decrease in
ABI underwent arteriography. All patients who had SFA
interventions also underwent duplex surveillance. Loss of
patency in either endovascular or the open-treated seg-
ments in HYBRID group was considered as loss of patency
for that limb. Reinterventions were performed for main-
taining patency, or when clinically indicated.
Statistical analysis. Data analysis was performed us-
ing SPSS 16.0 software (SPSS, Inc, Chicago, Ill). Kaplan-
Meier analysis and log rank test were used to compare
groups for primary patency (PP), assisted-primary patency
(APP), secondary patency (SP), limb salvage (LS), and
overall survival on an intent-to-treat basis.19 Continuous
variables are given as mean  standard deviation. Demo-
graphic comparisons were made using chi square test for
categorical variables, and by Mann-Whitney U test for
continuous variables. All P values were considered signifi-
cant if 0.05. Institutional Review Board approval was
obtained for the study.
RESULTS
Patients. A total of 654 patients (770 limbs; 99%
males) were included. There were 207 patients (226 limbs;
29%) in the OPEN group, 356 patients (436 limbs; 57%) in
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Fig 1. Fifty-seven-year-old smoker with coronary artery disease, chronic pulmonary obstructive disease, hypertension,
with 30-yard claudication and left ankle-brachial index of 0.35. He had restenosis of left iliac artery after previous stent
placement (a), and distal common femoral artery near occlusion (b), superficial femoral artery (SFA) occlusion with
reconstitution of diseased distal SFA (c). After exposure, the SFA occlusion and external iliac artery (EIA) stenosis was
crossed, guidewires were placed in the SFA and iliac arteries (d). After patch endarterectomy, the sheaths were inserted
in both directions and flow was reestablished (e). External iliac stenting and SFA stenting was completed (f, g).
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group. In the HYBRID group, 56 were simple (sHYBRID),
and the remaining 52 were treated with complex hybrid
procedures (cHYBRID).
Demographic and preoperative characteristics of pa-
tients are shown in Tables I and II. Patients in the EV group
were significantly older than the HYBRID group (P 
.004). Hypertension was more common in the HYBRID
Table I. Demographics, co-morbidities, presentation mod
endovascular, and hybrid groups
Open (n  226)
Age 67.8  10.3
CAD 60%
Hypertension 73%
DM 44%
CVD 17%
Hyperlipidemia 61%
COPD 26%
Renal insufficiency 24%
Dialysis 7%
ASA 2/3/4 7%/80%/13%
CLI 75%
AI/FP/IP 15/40/45%
AI, Aortoiliac; ASA, American Society of Anesthesiology; CAD, coronary
disease; CVD, cerebrovascular disease; DM, diabetes mellitus; EV, Endovas
1P  .004, Hybrid vs EV.
2P  .006, Hybrid vs Open, and EV.
3P  .014, Open vs EV; P  .017, Open vs Hybrid; P  .001, EV vs Hyb
4P  .001, Open vs EV; P  .037, Open vs Hybrid.
5P  .017, Hybrid vs EV.
6P  .025, Hybrid vs EV.
7P  .05, Open vs Hybrid for ASA 4.
8P  .001, Open vs EV; P  .033, EV vs Hybrid.
9P  .001, Open vs Hybrid; P  .029, EV vs Hybrid.
Table II. Demographics, co-morbidities, presentation
modes, and level of most distal intervention in simple
hybrid (sHYBRID) and complex hybrid (sHYBRID)
groups
sHYBRID
(n  56)
cHYBRID
(n  52) P value
Age 64.7  10.4 67.6  9.8 .054
CAD 55% 65% .329
Hypertension 82% 90% .271
DM 34% 27% .531
CVD 16% 23% .467
Hyperlipidemia 75% 71% .670
COPD 25% 42% .068
Renal insufficiency 11% 23% .121
Dialysis 5% 13% .191
ASA 2/3/4 4%/82%/14% 0%/69%/31% .0571
CLI 70% 77% .515
AI/FP/IP 39%/43%/18% 50%/37%/13% .523
AI, aortoiliac; ASA, American Society of Anesthesiology; CAD, coronary
artery disease; CLI, critical limb ischemia; COPD, chronic obstructive oc-
clusive disease; CVD, cerebrovascular disease; DM, diabetes mellitus; FP,
femoropopliteal; IP, infrapopliteal.
1P  .04 for ASA 4.group than other groups, and the OPEN group had lesshyperlipidemia than other groups. The HYBRID group
had more patients with chronic obstructive occlusive dis-
ease than EV, and more ASA 4 patients than the open
group, most of whom were in the cHYBRID group (31%,
vs 14% in sHYBRID; P  .04). DM was significantly more
in the EV group than the OPEN group, both of which were
significantly more frequent than the HYBRID group. Re-
nal insufficiency was less in the HYBRID than the EV
group, but dialysis dependence was similar between groups.
The indication for intervention was similar between the
OPEN and HYBRID groups, but there were less patients
with critical limb ischemia in the EV group. There were
fewer patients in the OPEN group who had aortoiliac
interventions, which was highest in the HYBRID group.
The revascularization procedures. The procedures
performed in open and endovascular treated patients are
listed in Table III (online only), and hybrid procedures are
listed in Table IV. More patients in the open group under-
went infrainguinal and distal procedures than those who
had endovascular and hybrid procedures, with proportion-
ately more patients having aortoiliac interventions in the
cHYBRID group (50%). Our approach to revascularization
changed over time, with a significant increase in endovas-
cular interventions (21% to 68%; P .001) and decrease in
open revascularizations (68% to 17%; P .001) before and
after the introduction of cHYBRID procedures, whereas
sHYBRID procedures decreased (10% to 6%; P  .072,
Table V). During the study period, 297 patients (39%) of
patient underwent multilevel revascularizations. Although
the sHYBRID procedures remained relatively unchanged,
cHYBRID procedures now comprised 25% of multilevel
nd level of most distal intervention in open,
 436) Hybrid (n  108) P value
 10.6 66.1  10.2 .0041
58% 60% .865
73% 86% .0142
54% 31% .0013
20% 19% .576
76% 73% .0014
22% 33% .0475
27% 17% .0666
6% 9% .526
5%/18% 2%/76%/22% .0927
62% 73% .0028
45/23% 44/40/16% .0019
disease; CLI, critical limb ischemia; COPD, chronic obstructive occlusive
FP, femoropopliteal; IP, infrapopliteal.es, a
EV( n
69.5
7%/7
32/
artery
cular;
rid.revacularizations (43% when combined with simple hybrid
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important to note that multilevel reconstructions in the
open and endovascular groups were all infrainguinal, with
97% of open and 62% of endovascular interventions involv-
ing the infrapopliteal level as the most distal level of inter-
vention, whereas the infrainguinal interventions comprised
61% and 50% of the sHYBRID and cHYBRID groups,
respectively.
The endovascular component of the sHYBRID group
was performed on the iliac arteries in 91% (51 limbs) with
Table IV. The procedures performed in simple
(sHYBRID) and complex hybrid (cHYBRID) groups
n (%)
sHYBRID procedures
CIA/EIA PTA/stent
Plus femoro-femoral bypass 12
Plus femoro-popliteal bypass 21
Plus femoral-distal bypass 7
Plus FEA 11
SFA PTA/stent plus pop distal bypass 3
FEA plus SFA stent 2
Total 56
cHYBRID procedures
CIA and/or EIA stent
Plus FEA 28
Plus FEA and SFA stent 5
Plus FEA and infrageniculate PTA/S 2
Plus femoro-femoral bypass 1
Plus femoro-femoral and SFA stent 2
Plus femoral-BK popliteal bypass 2
Plus femoral-distal bypass 6
FEA plus SFA stent 4
Femoro-femoral bypass plus SFA stent 1
Femoral-BK popliteal bypass
Plus infrapopliteal PTA/stent 1
Total 52
BK, Below-the-knee; CIA, common iliac artery; EIA, external iliac artery;
FEA, femoral endarterectomy; PTA, percutaneous luminal angioplasty;
SFA, superficial femoral artery.
Table V. The change of our approach to lower extremity
revascularizations in all and those requiring multilevel
reconstructions over time
6/1/2001-
9/26/03
9/26/03-
5/31/2008 P value
All patients
Open (n  226) 124 (68%) 101 (17%) .001
EV (n  436) 39 (21%) 398 (68%) .001
sHYBRID (n  56) 19 (10%) 37 (6%) .072
cHYBRID (n  52) 0 52 (9%) .001
Total (n  770) 182 588
Multilevel reconstructions
Open (n  105) 63 (73%) 42 (20%) .001
EV (n  84) 4 (5%) 80 (38%) .001
sHYBRID (n  56) 19 (22%) 37 (18%) .414
cHYBRID (n  52) 0 52 (25%) .001
Total (n  297) 86 211
EV, Endovascular.the remaining on the SFA. For iliac interventions, 11 (20%)were staged, endovascular component preceding the bypass
procedures. The endovascular-treated segment was TASC
A in 20 of the iliac arteries, and TASC B in 31 iliac arteries.
Three of the SFA lesions were TASC B, and the remaining
was TASC A. The most distal level of intervention was
femoropopliteal in 43% and infrapopliteal in 18% of pa-
tients.
The procedures performed in the cHYBRID group are
listed on Table IV. All components of the procedures were
performed simultaneously, and the most distal level of
intervention was aortoiliac/inguinal in 50%, femoropopli-
teal in 37%, and infrapopliteal in 13% of patients. Femoral
endarterectomy was performed in 39 patients (75%). In 19
patients either contralateral percutaneous access (n  18),
brachial access (n  6), or both (n  5) were used. PAGA
was obtained in all patients in this group, with 10 of them
having guidewires placed both in inflow and runoff vessels
(double PAGA). Eighteen of the treated iliac arteries were
TASC C, and 25 were TASC D. In the SFA, eight were
TASC C and five were TASC D. Three TASC A or B iliac
lesions were treated along with TASC C/D SFA lesions,
and two TASC A SFA lesions were treated along with
TASC C/D iliac lesions.
Early outcomes. The immediate technical success rate
was 96% for cHYBRID, and 100% for sHYBRID proce-
dures. There were two technical failures in the cHYBRID
group. The severely calcified iliac arteries could not be
crossed in one patient, necessitating an emergency axillary-
bifemoral bypass. The second patient had extensive embo-
lization to his liver, mesentery, and kidneys, likely due to
the guidewire manipulation in the aorta, and died due to
multiple system organ failure postoperatively.
The ipsilateral ABI increased from 0.40 0.25 to 0.84
0.18 in the OPEN group, 0.50  0.22 to 0.86  0.18 in
endovascular group, and 0.35 0.25 to 0.77 0.23 in the
HYBRID group. The postoperative ABI in the HYBRID
group was significantly less than the other two groups (P
.003), likely reflecting the most distal level of intervention
being more proximal in this group.
The LOS was significantly less in the endovascular
group (3.6  7.0 days) than both the OPEN (9.2  10.1
days) and HYBRID groups (6.9  7.3 days; P  .001 for
both), while LOS in the HYBRID group was significantly
less than the open group (P  .001). The LOS in the
sHYBRID group was longer than cHYBRID, but this was
not statistically significant (7.7  7.7 days vs 6.0  6.7
days; P  .122).
Postoperative complications are listed in Table VI. The
postoperative myocardial infarction (MI) and mortality
rates were highest in the HYBRID group (5.6% for MI,
6.4% for mortality, and 8.3% for combined MI/mortality).
All were significantly more than endovascular group (1.1%,
1.1%, and 2.1%, respectively; P  .01), whereas the differ-
ences were not significantly different in the OPEN group
(3.5%, 3.1%, and 4.4%; P  .391, .153, and .204 vs
HYBRID). Deep wound infections involving the graft were
similar between the OPEN and HYBRID groups (2.6% vs
2.8%; P  1.0), superficial wound infections were more
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the HYBRID group, two of the three deep infections
involving the grafts were preserved, whereas the third was
removed in an outside hospital, and the patient eventually
had an above-knee amputation.
There were seven 30-day mortalities in the HYBRID
group (three in sHYBRID, four in cHYBRID). Five of
these were following MI, and one was in a wheelchair-
bound obese patient who had a respiratory arrest in nursing
home, and one was the patient who developed multiple
system organ failure after massive embolization, which was
the only mortality directly related to the procedure. Two of
the patients were ASA 4, and three of the remaining five
patients had limited functional capacity with significant
coronary artery disease and other comorbidities.
Late outcomes. The mean follow-up was 30.3 20.7
months. The 12-month and 36-month PP rates in patients
who had aortoiliac level interventions in the sHYBRID
group (n  22) were 80%  9% and 75%  9.9%, and
similar to the cHYBRID group (87%  7% and 81%  9%;
P  .863). When compared with endovascular-treated
patients with complex anatomy (TASC II C or D, n  48;
98%  2% and 93%  4%), or open treated patients (n 
35; 91%  5% and 84%  7%), there was no statistically
significant difference (Fig 2). The 12-month and 36-month
SP rates in the sHYBRID group were 96%  4% and 84% 
9%, and in the cHYBRID group were 100% and 89% 7%
(P  .514), and these were similar to endovascular treated
(98%  2% and 93%  5%) and open treated (97%  3% and
94% 4%) patients (Fig 3). When infrainguinal level interven-
tions were compared, the 12-month and 36-month PP rates
for sHYBRID (n  34) were 86%  7% and 68%  9.5%,
which was similar to the cHYBRID group (n 26; 84% 8%
for both; P .649). These were similar to the EV group (n
298; 71% 3% and 57% 4%) and open treated group (n
191; 68%  4% and 52%  5%; Fig 4). The 12-month and
36-month SP rates in the sHYBRID group were 86%  7%
Table VI. Postoperative (30-day) complications in each
group
Open EV HYBRID
Non-fatal MI 3.5% 1.1% 5.6%
Death 3.1% 1.1% 6.4%
Graft/stent occlusion 1.8% 0.5% 0.9%
Major amputation 1.8% 2.1% 0.9%
Bleeding 1.3% 0.2% 0.9%
Pneumonia 0.5% 0 0
Pseudoaneurysm 0 0.9% 0
Seroma 0.9% 0 1.9%
Stroke 0.4% 0.2% 0.9%
DVT 0.4% 0 0
Gastrointestinal bleeding 0.4% 0 0
Bowel obstruction 0.4% 0 0
Iliac artery rupture 0 0 1.9%
Superficial infection 12.8% 0 4.7%
Deep infection 2.6% 0.2% 2.8%
DVT, Deep vein thrombosis; EV, endovascular; MI, myocardial infarction.and 72% 9%, and the cHYBRID group were 95% 5% and84% 11% (P .680). These were also similar to those who
had endovascular (87%  2 % and 61%  3%) and open
(75% 3% and 69% 4%) revascularizations (Fig 5).
Limb salvage rates in patients with critical limb isch-
emia were similar in the endovascular (12- and 36-month;
86% 2% and 80% 3%), sHYBRID (94% 4% and 80%
7%), and OPEN groups (80%  3% and 74%  4%) but
better in the cHYBRID group (100%; P  .014), and this
finding did not change when only infrainguinal interven-
tions were included (P  .044; cHYBRID vs others). The
survival rates were almost identical in all groups in this
cohort. The 12-, 36-, and 60-month survival in the OPEN
group was 80%  3%, 65%  4%, and 45%  4%, in
endovascular group was 83%  2%, 63%  3%, and 43% 
5%, and in the HYBRID group was 80%  4%, 64%  5%,
and 49%  7% (P  .963).
Loss of PP occurred in 18 patients (16 symptomatic, 2
asymptomatic) in the sHYBRID group, between 0 and 72
months. All but two patients with occlusions (13 patients)
had bypass graft occlusions, with patent endovascular
treated segments. Six patients needed reinterventions for
maintaining patency; two needed stent placement of the
previously treated iliac arteries with patent femorofemoral
bypasses (54 and 72 months), one patient needed restent-
ing of the restenosed SFA (42 months), one patient needed
thrombolysis for a symptomatic occlusion of SFA, and one
had anastomotic revision of the femorofemoral bypass (7
months). One patient with a patent femoropopliteal bypass
had occluded native popliteal artery, which was recanalized
at 67 months. Overall, 78% of loss of PP occurred due to
graft related events. Of the 13 occlusions, two were asymp-
tomatic, three had thrombolysis, two had thrombectomies
and revisions, three had redo bypasses, one had graft infec-
tion necessitating graft removal, and three had amputations
due to advanced foot ischemia. Overall, 7 of these 12
patients eventually underwent amputations.
Loss of PP occurred in nine patients in the cHYBRID
group between 3 and 48 months, eight of whom were
symptomatic. Six were related to abnormalities detected in
the endovascular treated segment (67%), and three were
related to the bypass. In the four patients who needed
interventions for maintaining patency, three had PTA/
stenting of their iliac artery (one patient), or SFA (two
patients), and one needed angioplasty of the endarterecto-
mized segment at 48 months. Of the five occlusions, one
was asymptomatic, three had thrombolysis followed by
PTA/restenting of iliac and/or SFA arteries, and one had
redo bypass. There were no amputations in this group.
Late (30 day) graft infections occurred in four pa-
tients in the HYBRID group, two of whom had repeat
interventions through the site at 12 and 15 months in
outside institutions. The remaining presented 2 and 3
months later with graft infections; one had graft removal in
an outside facility (which resulted in above-knee amputa-
tion), and the other had graft preservation. There were 13
(5.8%) late graft infections in the OPEN group, which was
not different than the HYBRID group (P  .596).
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Combining endovascular and open procedures was first
reported in the 1970’s, mostly involving high risk patients
undergoing iliac angioplasty for the donor iliac artery,
followed by femorofemoral bypass procedures. These were
usually performed in a staged fashion, with the interven-
tional radiologists performing the endovascular compo-
nent.6,7 Involvement of the surgeons resulted in using
combination procedures in patients with increased com-
plexity.10,23,24 The use of hybrid procedures has been
reported to constitute about 5% to 21%5,25 of the recon-
structions. Ebaugh et al25 reported a 7% increase in hybrid
reconstructions in a Nationwide Inpatient Sample (NIS)
database between 2001 and 2004, most of which were in
the simultaneous group. In our cohort, hybrid reconstruc-
tions constituted 14% of all reconstructions, with increased
use of complex hybrid procedures. Our experience with
hybrid procedures initially consisted of only selective use of
endovascular interventions for improving inflow in patients
requiring revascularizations. These simple hybrid proce-
dures constituted 10% of all revascularizations (22% of
multilevel revascularizations), and remained relatively sta-
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Fig 2. Primary patency in patients who had aortoilia
groups.ble over time, but with increased adoption of endovascularinterventions, the hybrid procedures started to include
patients whose endovascular revascularized segment had
complex disease (TASC C or D), now constituting 9% of all
revascularizations in our current experience (25% of multi-
level reconstructions). Overall, hybrid reconstructions cur-
rently constitute 15% of all revascularizarions and 43% of
multilevel reconstructions.
Half of our patients who had complex hybrid proce-
dures had aortoiliac reconstructions. Kashyap et al24 re-
ported a large series of aortoiliac occlusions, a significant
number of whom (21%) needed hybrid reconstructions,
most involving endarterectomies, and reported similar re-
sults with open bypasses from their institutions. Similar to
Kashyap et al,24 we perform a large number of percutane-
ous revascularizations in patients with aortoiliac occlusions,
and reserve the complex hybrid procedures only for those
who require endarterectomy and/or profundoplasty for
achieving an adequate runoff. We would like to point out
that it is important to identify patients who would best be
served with an endarterectomy as part of a complex endo-
vascular reconstruction, before attempting the endovascu-
lar recanalization, especially if the patient is not in an
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less of an issue with surgeons working in an operating room
with appropriate C-arm or endovascular suite; however, it
may be problematic in an interventional radiology suite or
cardiac catheter laboratory, especially in the absence of a
vascular surgery backup. Due to the procedures being
performed by surgeons in the operating room environ-
ment, we do have a low threshold for performing hybrid
procedures, and tend to complete the reconstruction in a
single stage, even in patients who can be staged.
Although the complexity of the endovascular treated
segment was reported to be affecting final outcomes by
some, others have suggested this not to be the case.26
Aburahma et al27 had significantly worse results in those
with 5 cm iliac lesions; however, most of the failures
were within 30 days. Interestingly, their results in pa-
tients with less iliac disease correlate with our findings in
the sHYBRID group in whom the endovascular treated seg-
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Fig 3. Secondary patency in patients who had aortoilia
groups.ment was rarely the site of late failure, reflecting more of thenatural history of atherosclerotic process. Similarly, Dough-
erty et al26 found that endovascular treated segment was
rarely a site of failure; however, most of the lesions treated
in their series were in the TASC A or B category. Although
the culprit lesions were mostly found in the endovascular
treated segments in our cHYBRID group, all were treated
by endovascular means with excellent final outcomes.
We would like to emphasize that obtaining inflow
and/or outflow guidewire access before making the arteri-
otomy is a key maneuver in hybrid procedures.17 Once we
cross the occlusion, we leave the wires in place, and perform
the surgical component of the procedure. We complete the
endovascular component after back-bleeding, and the
flow is established. Performing the endovascular compo-
nent in the end ensures that there is no stagnant blood in
the endovascular-treated segment while the arteries are
clamped.
One of the major goals of our study was to establish a
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dure was performed for a TASC A or B lesion “simple
hybrid” procedures, which mostly refers to the complexity
of the anatomy of the endovascular treated artery, and by
no means suggest that these are simple procedures. In fact,
the results in this group were very similar to the open
group, which simply reflects the fact that these were mainly
open procedures. These procedures can be performed si-
multaneously or in a staged fashion, and 20% of our patients
in the sHYBRID group were treated in a staged fashion. On
the other hand, we called the hybrid procedures “complex
hybrid,” when the endovascular-treated segment had
TASC C or D anatomy. These procedures enabled high-
risk patients to have revascularization with minimal inci-
sions, and they had similar results to endovascular-treated
patients, and comparable results to open revascularizations
in our series. Similar to other recently published series,23,24
femoral endarterectomy was a key component of complex
hybrid procedures in our series. In addition, brachial access,
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Fig 4. Primary patency in groups who had infrainguin
groups.or multiple accesses (contralateral femoral and transbra-chial) is not uncommon in these patients. We did not
classify hybrid procedures based on the endovascular com-
ponent being proximal, distal, or both of the open recon-
struction,16 because we think that it is the TASC classifica-
tion of the endovascular treated segments that will
determine the final outcome of the reconstruction, rather
than its relative anatomic location.
The patency rates in our patients are comparable to
those in the literature, although it is very difficult to make
meaningful comparisons due to the heterogeneity of the
cases in published series. We compared the patency rates of
aortoiliac and infrainguinal level interventions separately,
and did not find any significant differences among groups,
although the hybrid treated patients comprised of patients
who underwent multilevel revascularizations. Due to the
complexity of the anatomic and clinical presentation of these
patients, it is almost impossible to have comparable groups
when hybrid procedures are analyzed. It is important to note
that loss of patency occurred mostly in the endovascular-
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erventions. There was no statistical difference betweenal inttreated segment in the cHYBRID group, whereas the failure
line in
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hybrid procedures, which was not an unexpected finding. We
believe that the patency rates in hybrid procedures should be
reported considering both reconstructions, and not sepa-
rately, as was done in some studies.
The morbidity and mortality in our patients who un-
derwent hybrid procedures were significantly higher than
the endovascular group, and although not statistically sig-
nificant, they were higher than the open group. Five of the
seven mortalities in this group occurred in patients with
poor functional capacity, all of whom had significant CAD,
and only one patient died as a result of the procedure.
These patients were not otherwise candidates for multilevel
open revascularization procedures, and hybrid alternatives
were chosen as less invasive in an attempt to decrease their
morbidity and mortality rates, after medical optimization.
We hope to decrease these figures by our currently more
aggressive use of statin drugs and medical optimization and
patient selection process, which now involves a multidisci-
plinary meeting (in addition to preoperative medical clear-
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Fig 5. Secondary patency in patients who had infraing
groups except open vs endovascular; P  .018. Hashedance) in patients who are deemed excessive high risk.The limitations of our study include its retrospective
nature, involving an almost all-male (99%) population from
a single center. The groups are heterogeneous and are not
directly comparable; however, we believe that we have
emphasized these differences adequately, and we are not
making any recommendations for choosing treatment mo-
dality based on these comparisons.
CONCLUSIONS
Complex and simple hybrid procedures enable multi-
level revascularizations in high-risk patients with favorable
patency and limb salvage, and currently comprise 15% of all
revascularizations. Femoral endarterectomy plays a central
role, especially in complex hybrid repairs. An increased
perioperative morbidity and mortality was observed in the
hybrid group, likely due to attempting revascularization in
higher risk patients. The loss of patency following complex
hybrid procedures is more likely to be related to the endo-
vascular treated segment; however, excellent assisted pri-
mary and secondary patency rates can be achieved by rein-
24mo  36mo
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interventions. There is no statistical difference between
dicates the standard error 10%.uinalterventions.
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CIA, common iliac artery; EIA, external iliac artery; PTA, percutaneous
luminal angioplasty; SFA, superficial femoral artery.
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June 20101435.e1 Dosluoglu et alTable III (online only). The procedures performed in
open and endovascular treated patients
n (%)
Open procedures
Aorto-bifemoral bypass 14 (6%)
Axillary-bifemoral bypass 13 (6%)
Femoro-femoral bypass 11 (5%)
Femoral endarterectomy 8 (4%)
Femoral-popliteal bypass
Above-knee 44 (19%)
Below-knee 35 (15%)
Femoral-distal bypass 101 (45%)
Total 226
Endovascular (percutaneous)
procedures
Aorta/aortoiliac stent 9
CIA/EIA PTA/stent 131
Plus SFA PTA/stent 30
Plus infrapop PTA/stent 2
Plus SFA plus distal PTA 2
Femoropopliteal PTA/stent 156
Plus distal PTA 6
Profunda PTA 1
Infrageniculate PTA/stent 87
Technical failure 12 (8 SFA, 4 infrapopliteal)
Total 436
